Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

LUN07-130

A Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies

For full description, see www.clinicaltrials.gov.

Abstracts/Posters/Presentations:

  • D. Bodenmiller, S. Jalal, J. Turchi, J. Wu, Z. Yu, L. Einhorn. A phase I study of Amrubicin (AMR) and Cyclophosphamide in patients with advanced solid organ malignancies: Correlative analysis of a trial from the Hoosier Oncology Group LUN07-130. Accepted as abstract (Abstract # e17517) at the ASCO Annual Meeting, June 4-8 2011, Chicago, IL.
  • S. Jalal, J. Bufill, M. Guarino , N. Somaiah , K. Koneru, J. McClean, R.Sanborn, J. Wu, Z. Yu, L. Einhorn. A phase I study of Amrubicin (AMR) and Cyclophosphamide in patients with advanced solid organ malignancies: A trial from the Hoosier Oncology Group LUN07-130. Accepted as a Poster Presentation at the General Poster Session at the ASCO Annual Meeting, June 4-8 2011, Chicago, IL. J Clin Oncol 29: 2011 (suppl; abstr 7082)
  • Shadia Ibrahim Jalal, Nasser H. Hanna, Robin Zon, Gregory A. Masters, Hossein Borghaei, Karuna Koneru, Sunil S. Badve, Nagendra K Prasad, Neeta Somaiah, Jingwei Wu, Zhangsheng Yu, Lawrence H. Einhorn. Final results of a phase I study of amrubicin and cyclophosphamide in patients with advanced solid organ malignancies: HOG LUN 07-130. Presented at the general poster session, lung cancer – non-small cell local-regional/ small cell/other thoracic cancers at the ASCO Annual Meeting, May 31, 2014, Chicago IL. J Clin Oncol 32:5s, 2014 (suppl; abstr 7594). See abstract.

Manuscripts/Articles:

  • Jalal SI, Hanna N, Zon R, Masters GA, Borghaei H, Koneru K, Badve S, Prasad N, Somaiah N, Wu J, Yu Z, Einhorn L. Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies: HOG LUN 07-130. Am J Clin Oncol. 2017 Aug;40(4):329-335. doi: 10.1097/COC.0000000000000160. See abstract.